CARLSMED, INC.
Close on Oct 19, 2026
- Market cap
- $371.43M
- P/E (TTM)
- –
- Dividend yield
- –
About Carlsmed
Surgical & Medical Instruments & Apparatus, SIC 3841
Carlsmed, Inc. is a medical technology company that develops artificial intelligence-enabled personalized solutions for spine fusion surgery. Its core offering is the aprevo Technology Platform, which integrates digital surgical planning software with custom-designed interbody implants tailored to each patient's specific spinal anatomy, alongside single-use surgical instruments. The platform addresses spinal conditions including degenerative disc disease and adult spinal deformity across both lumbar and cervical fusion procedures. Carlsmed sells its personalized implants and surgical solutions directly to hospitals and ambulatory surgical centers for use by spine surgeons.
Carlsmed focuses its commercial activities within the United States, utilizing a direct sales organization alongside independent sales agents to market its systems. As of December 31, 2025, 253 surgeon users have completed one or more spine fusion procedures using the aprevo platform. The company's corporate headquarters and principal executive offices are located in Carlsbad, California.
Summary of the business section of Carlsmed's latest annual report, written by StockData.
Company profile
Company
- Legal name
- CARLSMED, INC.
- Headquarters
- Carlsbad, CA
- Address
- 1800 Aston Avenue, Suite 100 92008
- Phone
- (858) 295-9290
- Employees
- 24, Dec 31, 2025
- Industry
- Surgical & Medical Instruments & Apparatus
- Incorporated in
- Delaware
- Fiscal year ends
- December 31
- Auditor
- Ernst & Young LLP, San Diego, California
Stock & identifiers
- Ticker
- CARL
- Exchange
- Nasdaq
- IPO date
- Jul 24, 2025
- Shares outstanding
- 27M, Aug 3, 2026
- Filer category
- <br>Emerging growth company
- SEC CIK
- 1794546
- CUSIP
- 14280C105
- ISIN
- US14280C1053
- LEI
- 5299003NUOF1GRY8UX10
- EIN
- 83-1081863
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Michael Cordonnier | CEO, President, Director | 1,517,213 |
| Niall Casey | Chief IP Officer, Director | 982,562 |
| Jennifer Kamocsay | Chief Legal Officer | 56,222 |
| Richard Heppenstall | CFO, Treasurer | 89,286 |
| Jeffrey Bertolini | Chief Operating Officer | 22,489 |
| William Scott Durall | Chief Commercial Officer | 44,977 |
| Leonard M. Greenstein | CFO, Treasurer | 188,346 |
| Kevin Sidow | Director | 73,264 |
| Jonathan D. Root | Director | 716,221 |
| Kevin C. Oboyle | Director | 31,031 |
| Philip M. Young | Director | 84,364 |
| Robert Mittendorff II | Director | 5,013,839 |
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| Jul 24, 2025 | IPO | Initial public offering priced (424B4 prospectus) |
| Jul 21, 2025 | Listing | Registration of securities on an exchange (Form 8-A) |